Hektas Ticaret T.A.S.
HEKTS.IS
Unten findest du den Live-Kurs für Hektas Ticaret T.A.S. (HEKTS.IS), einen 1-Jahres-Chart, 8 Indikatoren (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) und einen Vergleichsmodus. Hinzufügen zum Portfolio, auf die Beobachtungsliste setzen oder einen Preisalarm einrichten — alles in einem.
- Prev close
- $0.12
- Volume
- $20.23M
- Market cap
- $1.06B
- Currency
- USD (native TRY)
Financials
- 52w high
- ₺5.27
- 52w low
- ₺2.76
- 52w change
- 40.26%
- Day high
- ₺4.58
- Day low
- ₺4.28
- PEG
- 0.85
- Price / Book
- 246.11
- Beta (5Y)
- -0.31
- Enterprise value
- 48.42B
- EV / Revenue
- 8.62
- EV / EBITDA
- -26.35
- EPS (TTM)
- -₺0.42
- Payout ratio
- 0.00%
- Revenue (TTM)
- 5.62B
- EBITDA
- -1.84B
- Free cash flow
- -298.56M
- Total cash
- 1.98B
- Total debt
- 12B
- Debt / Equity
- 75.09
- Current ratio
- 0.58
- Quick ratio
- 0.32
- Profit margin
- -63.18%
- Gross margin
- -2.98%
- Return on assets
- -6.11%
- Return on equity
- -23.47%
- Shares outstanding
- 8.43B
- Float
- 3.76B
Hektas Ticaret T.A.S. manufactures, imports, and markets agricultural products, fertilizers and veterinary medicines in Turkey. The company's crop protection products include fungicides, herbicides, insecticides, acaricides, fumigants and nemathists, harvesting aids and plant growth regulators, winter struggle medicines and summer oils, spreads-adhesives, biological products, and feromons. It also offers smart base, leaf, pure, and fertilizers; organominerals; drip irrigation; biological preparation; and other plant nutrition products. In addition, the company provides ruminant, poultry, and pet products, as well as environmental health and seeds products. Hektas Ticaret T.A.S. was incorporated in 1956 and is headquartered in Gebze, Turkey.
Analyst & Risk
- Beta (vs S&P 500)
- -0.31
- very stable
- 52-week change
- 40.26%
- Debt / Equity
- 75.09
- very high leverage
- Current ratio
- 0.58
- Quick ratio
- 0.32
- ROE
- -23.47%
- ROA
- -6.11%
- PEG ratio
- 0.85
- potentially undervalued
- EV / Revenue
- 8.62
- EV / EBITDA
- -26.35
- Revenue growth
- -18.70%
- EBITDA
- -1.84B
- Free cash flow
- -298.56M
- Total cash
- 1.98B
- Total debt
- 12B
- Insider holdings
- 55.37%
- Institutional
- 3.81%
Aktuelle Nachrichten
- Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH TrialMarketBeat6m ago
- Uber reveals an unexpected problem behind the AI boomTheStreet7m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily8m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.9m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.11m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory13m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool13m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire14m ago
Live-Diskussion
Anmelden to join the discussion.
- Noch keine Kommentare. Sei der Erste.